Revenio Group: Strategy shifts to connected eye health, targeting 5%-10% growth and 25% EBITDA by 2029
The updated strategy focuses on leading the shift from vision care to connected eye health, supported by the Visionix acquisition, expanded product portfolio, and a unified operational model. Financial targets include 5%-10% organic sales growth and 25% adjusted EBITDA by 2029, with €20m in synergi…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.